Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
Summary
- Eligibility
- for people ages 18-99 (full criteria)
- Location
- at Orange, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Nadine Abi-Jaoudeh, MD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UC Irvine
- Nadine Abi-Jaoudeh, MD
Clinical Professor, Radiological Sciences, School of Medicine. Authored (or co-authored) 68 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- ABK Biomedical
- ID
- NCT05953337
- Study Type
- Interventional
- Participants
- Expecting 120 study participants
- Last Updated